TP53 and cancer: In the TP53 truncating mutation group, TP53 is significantly positively correlated with immune score, as well as stromal score and estimate score in specific cancers, such as BRCA, HNSC, LIHC, LUAD, LUSC, SKCM, PAAD, SARC, and STAD.